Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components
- PMID: 19924735
- DOI: 10.1002/uog.7464
Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components
Abstract
Objective: To determine whether intravenous contrast ultrasound examination is superior to gray-scale or power Doppler ultrasound for discrimination between benign and malignant adnexal masses with complex ultrasound morphology.
Methods: In an international multicenter study, 134 patients with an ovarian mass with solid components or a multilocular cyst with more than 10 cyst locules, underwent a standardized transvaginal ultrasound examination followed by contrast examination using the contrast-tuned imaging technique and intravenous injection of the contrast medium SonoVue(R). Time intensity curves were constructed, and peak intensity, area under the intensity curve, time to peak, sharpness and half wash-out time were calculated. The sensitivity and specificity with regard to malignancy were calculated and receiver-operating characteristics (ROC) curves were drawn for gray-scale, power Doppler and contrast variables and for pattern recognition (subjective assignment of a certainly benign, probably benign, uncertain or malignant diagnosis, using gray-scale and power Doppler ultrasound findings). The gold standard was the histological diagnosis of the surgically removed tumors.
Results: After exclusions (surgical removal of the mass > 3 months after the ultrasound examination, technical problems), 72 adnexal masses with solid components were used in our statistical analyses. The values for peak contrast signal intensity and area under the contrast signal intensity curve in malignant tumors were significantly higher than those in borderline tumors and benign tumors, while those for the benign and borderline tumors were similar. The area under the ROC curve of the best contrast variable with regard to diagnosing borderline or invasive malignancy (0.84) was larger than that of the best gray-scale (0.75) and power Doppler ultrasound variable (0.79) but smaller than that of pattern recognition (0.93).
Conclusion: Findings on ultrasound contrast examination differed between benign and malignant tumors but there was a substantial overlap in contrast findings between benign and borderline tumors. It appears that ultrasound contrast examination is not superior to conventional ultrasound techniques, which also have difficulty in distinguishing between benign and borderline tumors, but can easily differentiate invasive malignancies from other tumors.
Copyright 2009 ISUOG. Published by John Wiley & Sons, Ltd.
Similar articles
-
The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.Ultrasound Obstet Gynecol. 2007 May;29(5):512-6. doi: 10.1002/uog.4013. Ultrasound Obstet Gynecol. 2007. PMID: 17444549
-
Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.Ultrasound Obstet Gynecol. 1999 Oct;14(4):273-83. doi: 10.1046/j.1469-0705.1999.14040273.x. Ultrasound Obstet Gynecol. 1999. PMID: 10586480
-
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.Ultrasound Obstet Gynecol. 2011 Oct;38(4):456-65. doi: 10.1002/uog.9030. Epub 2011 Sep 13. Ultrasound Obstet Gynecol. 2011. PMID: 21520475
-
[Sonographic diagnosis of presumed benign ovarian tumors].J Gynecol Obstet Biol Reprod (Paris). 2013 Dec;42(8):730-43. doi: 10.1016/j.jgyn.2013.09.028. Epub 2013 Nov 5. J Gynecol Obstet Biol Reprod (Paris). 2013. PMID: 24200073 Review. French.
-
Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.Ultrasound Obstet Gynecol. 2013 Jan;41(1):80-9. doi: 10.1002/uog.12308. Epub 2012 Dec 17. Ultrasound Obstet Gynecol. 2013. PMID: 23001924 Review.
Cited by
-
Contrast-enhanced ultrasonography for differential diagnosis of adnexal masses.Front Oncol. 2022 Oct 20;12:968759. doi: 10.3389/fonc.2022.968759. eCollection 2022. Front Oncol. 2022. PMID: 36338700 Free PMC article.
-
A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses.Medicine (Baltimore). 2018 Jul;97(29):e11536. doi: 10.1097/MD.0000000000011536. Medicine (Baltimore). 2018. PMID: 30024542 Free PMC article.
-
Parametric mapping of contrasted ovarian transvaginal sonography.Ultrasound Q. 2015 Jun;31(2):117-23. doi: 10.1097/RUQ.0000000000000125. Ultrasound Q. 2015. PMID: 26002525 Free PMC article.
-
Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population.Reprod Sci. 2023 Mar;30(3):854-864. doi: 10.1007/s43032-022-01054-2. Epub 2022 Aug 23. Reprod Sci. 2023. PMID: 35999442
-
Clinical value of quantitative analysis of contrast-enhanced ultrasonography in the differential diagnosis of benign and malignant pelvic tumors.Quant Imaging Med Surg. 2023 Oct 1;13(10):6636-6645. doi: 10.21037/qims-23-582. Epub 2023 Aug 24. Quant Imaging Med Surg. 2023. PMID: 37869279 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical